Skin safety test of M118104 in healthy adults

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2031240385

Enrollment

Registered

2024-10-09

Start date

2024-10-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sebum deficiency, progressive palmar keratoderma,etc.

Interventions

Single administration of M118104

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Males and females who are 18 to under 65 years of age at the time of informed consent.

Exclusion criteria

Exclusion criteria: (1)Individuals with a history or complications including liver disease, renal disease, heart and other cardiovascular diseases, digestive disease, blood disease,etc, which are considered inappropriate for participation in the post-marketing clinical trial. (2)Individuals with a history or complications of contact dermatitis including tape dermatitis, and mechanical urticaria. (3)Individuals who the Investigator considers ineligible to be subjects.

Design outcomes

Primary

Measure	Time frame
(1)Skin safety: (2)Safety: Adverse events, laboratory tests, vital signs	—

Contacts

Public ContactClinical Trials Information -

Maruho Co.,Ltd. Kyoto R&D Center

ctinfo@mii.maruho.co.jp+81-75-325-3279

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026